A7GJ81 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibzjgv7kqah5isefqvvrkz6hebna4f2n2oasyism4efhoy376i7qe/metadata.json
IPFS of structure file: 
bafybeicruvwktvvv4ttasvim2jczm55gbg5qqe5vdbuumkfxjexavogibu/AF-A7GJ81-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4517351815Dbf177e3D333475e412F3f4099f15c
First NFT owner address (bech32): 
genesis1g5tn2xq4m0ch0c7nxdr4usf08aqfnu2u452vmk
Current NFT ID #388313 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388313
Accession (UniProt):
A7GJ81
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Langeland / NCTC 10281 / Type F)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7GJ81 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7GJ81|RPOC_CLOBL DNA-directed RNA polymerase subunit beta' OS=Clostridium botulinum (strain Langeland / NCTC 10281 / Type F) OX=441772 GN=rpoC PE=3 SV=1 MFELNNFDALQIGLASPEKIREWSRGEVKKPETINYRTLKPERDGLFCERIFGPMKDWECHCGKYKRIRYKGIVCDRCGVEVTKAKVRRERMGHIELAAPVSHIWYFKGIPSRMGLILDMSPRALEKVLYFASYVVLDPKETPLLKKQLLNEKEYRESIDKYGDDSFVAAMGAEAVKTLLDEIDLEQSSIELKEELKTSTGQKKIRIIRRLEVVESFRKSGNRPDWMVIDVIPVIPPDLRPMVQLDGGRFATSDLNDLYRRVINRNNRLKKLLDLGAPDIIVRNEKRMLQEAVDALIDNGRRGRPVTGPGNRPLKSLSDMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPELKMYQCGLPKEMALELFKPFVMKKLVQNGLAHNIKSAKRMVERVQPQVWDVLEEVISDHPVLLNRAPTLHRLGIQAFQPVLVEGRAIKLHPLVCTAYNADFDGDQMAVHVPLSVEAQAEARFLMLAAHNILKPSDGKPVSVPTQDMVLGSYYLTMDKDGVKGEGKVFSCPEEVLMAYQCKAVDIHAKIKVRLKKVIDGETIEGIIETTPGKIIFNESIPQDLGYIDRTIPENKLKLEVDFLVSKKTLGGIITKCYMKHGATKTSIMLDKIKAKGYHYSTIGAITISTSDMVVPESKRELLENTEKQVEKIQKMYRRGFISEEERYEKVIDLWTKTTEDVANALMESLDSFNPIYMMADSGARGSKSQIKQLAGMRGLMANPSGKILELPIKASFREGLDVLEYFISTHGARKGNADTALKTADSGYLTRRLVDVSQDVIVRQEDCGTEEGYEVSEIKEGNEVIEPLVERLSGRYPSEDIIHPTTGEVIVKRNTYMDEDIAQKVSDAGIKKVKIRSVFTCKSKHGVCARCYGMNMGTSQKIHIGEAVGIVAAQSIGEPGTQLTMRTFHTGGVAGADITQGLPRVEELFEARKPKGLAIVSEVSGTVKMEETKKKRTIIVVTDDGEEVSYDIPFGSRIKVKNGDIISAGDEITEGSINPHDILRIKGVDGVKNYLLSEVQKVYRLQGVDINDKHLEVVIRQMTRKIKIEDSGDTELLPGTMIDVFDFEEANREILEKGGEPAVGRIALLGITKAALATDSFLSAASFQETTRVLTDAAIKGKIDPLLGLKENVIIGKLIPAGTGMTRYRSIQINTDDENIEEDSMDSMEV